| http://dbpedia.org/ontology/abstract
|
サブコメリン(Sabcomeline)は、M1受容体の選択的パーシャルアゴニストで、アルツハイマー病の治療薬として開発が進められた。結果不良で開発中止になる前に第3段階の治験まで進んだ。
, La sabcomelina (Memric; SB-202,026) es un … La sabcomelina (Memric; SB-202,026) es un agonista parcial selectivo del receptor M1 que estaba en desarrollo para el tratamiento de la enfermedad de Alzheimer. Llegó a los ensayos clínicos de fase III antes de ser descontinuado debido a los malos resultados.scontinuado debido a los malos resultados.
, Sabcomeline (Memric; SB-202,026) is a selective M1 receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.
|
| http://dbpedia.org/ontology/casNumber
|
159912-58-0
, 159912-53-5
|
| http://dbpedia.org/ontology/chEMBL
|
134641
|
| http://dbpedia.org/ontology/fdaUniiCode
|
A24BK93DRR
, P8P92V596C
|
| http://dbpedia.org/ontology/pubchem
|
9577995
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Sabcomeline_skeletal.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
25288860
|
| http://dbpedia.org/ontology/wikiPageLength
|
2014
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1094691186
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Partial_agonist +
, http://dbpedia.org/resource/Alzheimer%27s_disease +
, http://dbpedia.org/resource/Category:Quinuclidines +
, http://dbpedia.org/resource/Milameline +
, http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/Phase_III_clinical_trials +
, http://dbpedia.org/resource/Category:Oximes +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Muscarinic_acetylcholine_receptor_M1 +
, http://dbpedia.org/resource/Alvameline +
, http://dbpedia.org/resource/Tazomeline +
, http://dbpedia.org/resource/Category:Nitriles +
, http://dbpedia.org/resource/Binding_selectivity +
, http://dbpedia.org/resource/Category:Muscarinic_agonists +
, http://dbpedia.org/resource/Xanomeline +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/c
|
10
|
| http://dbpedia.org/property/casNumber
|
159912
|
| http://dbpedia.org/property/chembl
|
134641
|
| http://dbpedia.org/property/chemspiderid
|
7852359
|
| http://dbpedia.org/property/h
|
15
|
| http://dbpedia.org/property/index2Label
|
HCl
|
| http://dbpedia.org/property/iupacName
|
-N-methoxyquinuclidine-3-carboximidoyl cyanide hydrochloride
|
| http://dbpedia.org/property/iupharLigand
|
306
|
| http://dbpedia.org/property/legalStatus
|
Never marketed
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
1
|
| http://dbpedia.org/property/pubchem
|
9577995
|
| http://dbpedia.org/property/smiles
|
C2CC1CCN2CC1\C=N\OC
|
| http://dbpedia.org/property/unii
|
P8P92V596C
, A24BK93DRR
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Anti-dementia_drugs +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Muscarinic_acetylcholine_receptor_modulators +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Nitriles +
, http://dbpedia.org/resource/Category:Muscarinic_agonists +
, http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/Category:Oximes +
, http://dbpedia.org/resource/Category:Quinuclidines +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/M +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Sabcomeline?oldid=1094691186&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Sabcomeline_skeletal.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Sabcomeline +
|
| owl:sameAs |
http://ja.dbpedia.org/resource/%E3%82%B5%E3%83%96%E3%82%B3%E3%83%A1%E3%83%AA%E3%83%B3 +
, http://rdf.freebase.com/ns/m.09gm1l6 +
, http://www.wikidata.org/entity/Q7396015 +
, http://sh.dbpedia.org/resource/Sabkomelin +
, http://es.dbpedia.org/resource/Sabcomelina +
, http://sr.dbpedia.org/resource/Sabkomelin +
, http://fa.dbpedia.org/resource/%D8%B3%D8%A7%D8%A8%DA%A9%D9%88%D9%85%D9%84%DB%8C%D9%86 +
, http://dbpedia.org/resource/Sabcomeline +
, https://global.dbpedia.org/id/4vBeu +
, http://yago-knowledge.org/resource/Sabcomeline +
|
| rdf:type |
http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/ontology/Place +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/Statement106722453 +
, http://dbpedia.org/class/yago/Communication100033020 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatOximes +
, http://dbpedia.org/class/yago/Oxime114972092 +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/Nitrile114827346 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/WikicatNitriles +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/MolecularFormula106817173 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Formula106816935 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/WikicatMolecularFormulas +
, http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Message106598915 +
|
| rdfs:comment |
La sabcomelina (Memric; SB-202,026) es un … La sabcomelina (Memric; SB-202,026) es un agonista parcial selectivo del receptor M1 que estaba en desarrollo para el tratamiento de la enfermedad de Alzheimer. Llegó a los ensayos clínicos de fase III antes de ser descontinuado debido a los malos resultados.scontinuado debido a los malos resultados.
, Sabcomeline (Memric; SB-202,026) is a selective M1 receptor partial agonist that was under development for the treatment of Alzheimer's disease. It made it to phase III clinical trials before being discontinued due to poor results.
, サブコメリン(Sabcomeline)は、M1受容体の選択的パーシャルアゴニストで、アルツハイマー病の治療薬として開発が進められた。結果不良で開発中止になる前に第3段階の治験まで進んだ。
|
| rdfs:label |
サブコメリン
, Sabcomeline
, Sabcomelina
|
